Monitoring of heparin therapy beyond the anti-Xa activity assay: Evaluation of a thrombin generation assay.

Pauline VermeirenArne VandeveldeHarlinde PeperstraeteKatrien M J Devreese

Published in: International journal of laboratory hematology (2022)

TGA seems insufficiently sensitive for low concentrations of LMWH. There may be an added value of the TGA for monitoring UFH in so-called heparin-resistant patients. Therefore, the TGA has the potential to be introduced as an additional tool for monitoring heparin therapy.

Keyphrases

venous thromboembolism
end stage renal disease
growth factor
high throughput
ejection fraction
chronic kidney disease
peritoneal dialysis
stem cells
bone marrow
cell therapy
human health
smoking cessation
patient reported